Wed.Jan 08, 2025

article thumbnail

3 trial readouts that could shake up the obesity market this year

PharmaVoice

A wave of new weight loss treatments is on the way, and drugmakers are scrambling for a foot in the door.

Marketing 109
article thumbnail

Galapagos Keeps Focus on Cancer Cell Therapy, Spins Out Rest of Biz Into NewCo Backed by €2.4B

MedCity News

Galapagos said the planned business separation will leave the legacy company free to focus on developing cell therapies for cancer. An accompanying corporate restructuring will shave Galapagoss headcount by 40%. The post Galapagos Keeps Focus on Cancer Cell Therapy, Spins Out Rest of Biz Into NewCo Backed by 2.4B appeared first on MedCity News.

article thumbnail

Novo Nordisk swells alliance with AI firm Valo Health

pharmaphorum

Novo Nordisk almost doubles the scale of its R&D alliance with AI specialist Valo Health, which now spans 20 programmes and a value of up to $4.6bn.

89
article thumbnail

Novo Nordisk Adds Obesity and Diabetes to AI Drug Research Pact With Flagship’s Valo Health

MedCity News

Novo Nordisk and Valo Health have collaborated on the development of cardiovascular disease drugs since 2023. Expanding the alliance to cardiometabolic diseases nearly doubles the number of programs covered under the agreement. The post Novo Nordisk Adds Obesity and Diabetes to AI Drug Research Pact With Flagships Valo Health appeared first on MedCity News.

article thumbnail

5 Ways You Can Win Faster with Gen AI in Sales

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

article thumbnail

Angelini Ventures co-leads Series A financing in Neumirna Therapeutics

PharmaTimes

Investment to support RNA therapeutics for epilepsy and neurological disorders

Leads 86
article thumbnail

Study: Why Quick Fixes Don’t Work in Workplace Wellness

MedCity News

By grounding wellness programs in behavior-change science, employers can empower their people to build healthier, more sustainable habits. The post Study: Why Quick Fixes Dont Work in Workplace Wellness appeared first on MedCity News.

More Trending

article thumbnail

What Keeps Healthcare CIOs Up at Night: Balancing Technology Investments with Consumer Expectations 

MedCity News

When it comes to managing inbound phone calls, underperformance has devastating cost implications. The post What Keeps Healthcare CIOs Up at Night: Balancing Technology Investments with Consumer Expectations appeared first on MedCity News.

article thumbnail

11 blockbuster drugs to look out for in 2025

pharmaphorum

Clarivate has revealed 11 drugs due to launch in 2025 that could top $1 billion in annual sales or be clinical 'game changers' in the next five years.

Sales 83
article thumbnail

Intermountain Health Sells Its Behavioral Health Risk Model to Neuroflow

MedCity News

Neuroflow acquired Intermountain Healths behavioral health risk analytics model to integrate into its software platform. The model identifies which patients may be at risk of experiencing mental health crises so that care teams can step in to provide timely support. The post Intermountain Health Sells Its Behavioral Health Risk Model to Neuroflow appeared first on MedCity News.

article thumbnail

J&J says Rybrevant combo has survival edge over Tagrisso

pharmaphorum

Rybrevant plus Lazcluze extended median OS by more than a year compared to Tagrisso in the MARIPOSA trial in treatment-naive, EGFR-mutated NSCLC

78
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Understanding the Ethics of AI in ABA Therapy

MedCity News

Certified clinicians and therapists have specific ethical foundations and analytic responsibilities to uphold that might not apply to all members of the healthcare field. The post Understanding the Ethics of AI in ABA Therapy appeared first on MedCity News.

Ethics 65
article thumbnail

Galapagos unveils plan to split, hiving off its drugs unit

pharmaphorum

Belgian biotech Galapagos is mixing things up again via a plan to split in two, separating its drug development and cell therapy operations.

72
article thumbnail

FDA awards GSA breakthrough status for relapsed osteosarcoma treatment

Pharmaceutical Technology

GSK has gained US FDA breakthrough therapy designation for GSK'227 to treat adults with relapsed or refractory osteosarcoma.

FDA 64
article thumbnail

Biopharma in 2025: Outlook for Obesity Meds, Drug Prices, Regulation & More

MedCity News

Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year. Other things to look for include more widespread adoption of artificial intelligence technologies and the IPO markets return to normal levels. The post Biopharma in 2025: Outlook for Obesity Meds, Drug Prices, Regulation & More appeared first on MedCity News.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Behind the Headlines: 2024 Year in Review

PharmaTech

Vanessa Almendro, Elliot Berger, Benjamin McCloud, and Turna Ray go behind the headlinesto discuss 2024s biggest trends in the pharmaceutical industry, as well as the unforeseen outcomes that took us by surprise.

article thumbnail

Accolade Gets a Do-Over With Transcarent’s $621M Acquisition

MedCity News

Transcarent is planning to acquire Accolade for $621 million, the companies announced Wednesday. The two companies are very complementary and the deal gives Accolade a chance to turn things around after struggling in the public market, experts say. The post Accolade Gets a Do-Over With Transcarent’s $621M Acquisition appeared first on MedCity News.

article thumbnail

PostEra Expands Pfizer Partnership with AI Lab and ADC Collaborations

PharmaTech

The AI Lab was launched almost exactly three years ago and has produced several programs so far, at least one of which achieved its first scientific stage gate 40% faster than the teams originally forecasted.

59
article thumbnail

Sanofi taps Alloy Therapeutics for CNS antisense drug development

Pharmaceutical Technology

As part of the agreement, Sanofi will provide Alloy with upfront license fees and near-term preclinical milestone payments up to $27.5m.

59
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Making Your National Sales Meeting Count: A Training Leader’s Guide to Success

Quantified

Let’s face it planning a National Sales Meeting (NSM) for life sciences teams can feel like orchestrating a complex clinical trial. You need the right content, good time management, and strong execution. Our customers have been in your shoes, so we wanted to share some practical strategies to help you create an NSM that transforms your field teams’ capabilities.

article thumbnail

MSD’s HPV vaccine gains China NMPA’s expanded approval for males

Pharmaceutical Technology

China's National Medical Products Administration has granted expanded approval to MSD's GARDASIL for use in males aged nine to 26 years.

Medical 59
article thumbnail

Transfusing More Blood to Heart Attack Patients With Anemia Reduces Risk of Death

Pharmacy Times

Data from a follow-up at 6 months show a reduced risk of all-cause mortality in heart attack patients with anemia who receive a liberal transfusion strategy compared with a restrictive one.

article thumbnail

Chugai and Araris enter $780m ADC research collaboration

Pharmaceutical Technology

Araris will use its linker technology to generate multi-warhead ADCs for undisclosed targets provided by Chugai.

59
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Reuters Pharma USA 2025

Pharma Marketing Network

Reuters Pharma USA 2025 will unite senior pharma leaders across commercial, marketing, medical affairs, patient engagement, market access, real world evidence and data for two days of learnings in Philadelphia. The 2025 agenda is streamed by priority spotlighting use cases and tangible learnings across the key topic areas of customer engagement, tools and technology, value demonstration, and future proofing strategies.

Pharma 52
article thumbnail

EMA gives OMPD to Actuate’s pancreatic cancer therapy

Pharmaceutical Technology

Actuate Therapeutics has gained OMPD from the EMA for elraglusib aimed at treating pancreatic ductal adenocarcinoma (PDAC).

59
article thumbnail

Swoop Acquires MyHealthTeam

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

Vertex and Orna sign partnership to improve efficiencies of gene therapies 

Pharmaceutical Technology

Orna will receive a $65m upfront payment and is eligible to receive potential milestone payments and royalties.

59
article thumbnail

10 Ways to Leverage Buyer Signals and Drive Revenue

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.

article thumbnail

The Association Between Social Risks and Nonadherence to Cancer Screening Guidelines

Pharmaceutical Commerce

What is the value in US adults addressing these risks, and how do social determinants of health play a role?

52
article thumbnail

Picnic Health Partners With Orsini to Improve Rare Disease Data

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

Clinical trial trends in 2025: Investment headwinds, wearables, and targeted AI uses

Pharmaceutical Technology

With clinical trials facing multiple challenges, digital solutions could provide the answer. We identify the key trends to watch in 2025.

52
article thumbnail

Addressing Misconceptions Surrounding Psychedelics

Pharmaceutical Commerce

In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jon Kostas, executive director, Association for Prescription Psychedelics (APP), addresses the importance of stopping the spread of misinformation when it comes to psychedelics.

article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten